TEICOS

Teicoplanin 400mg Injection

Overview:

Teicoplanin is a glycopeptide antibiotic primarily used for severe Gram-positive bacterial infections. It is structurally similar to vancomycin but has a longer half-life, allowing for less frequent dosing. Teicoplanin is particularly useful in treating infections caused by multi-resistant organisms, making it an essential drug in hospital settings.


  • Class
  • Dosage
  • Indications
  • Mechanism of action

Glycopeptide antibiotic

400 mg every 12 hr for 3 doses, then 400 mg once a day, iv

Teicoplanin 400mg Injection can be used in the treatment of the following conditions:

  • Methicillin-resistant Staphylococcus aureus (MRSA) infections
  • Severe skin and soft tissue infections
  • Bone and joint infections (osteomyelitis)
  • Endocarditis (heart valve infections)
  • Pneumonia caused by resistant bacteria
  • Septicemia (blood infections)
  • Clostridium difficile-associated diarrhea (as an alternative to vancomycin)

Inhibits bacterial cell wall synthesis by binding to peptidoglycan precursors, preventing cross-linking and leading to bacterial death.

Copyright by Neiss Labs Ltd 2025. All rights reserved.